NCT06929260 - A Study to Evaluate the Effect of Ceralasertib on Drug X, Drug Y and Drug Z | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 21, 2025

Primary Completion Date

November 12, 2025

Study Completion Date

March 2, 2026

Conditions

Advanced Solid Tumours

Interventions

DRUG

Ceralasertib

Participants will receive repeated dosing of ceralasertib from Day 1 to Day 7 until steady state.

DRUG

Drug X

Participants will receive a single dose of Drug X on Day 5 and Day 22.

DRUG

Drug Y

Participants will receive a single dose of Drug Y on Day 7 and Day 28.

DRUG

Drug Z

Participants will receive a single dose of Drug Z on Day 7 and Day 28.

Trial Locations (4)

SUSPENDED

Research Site, Madrid

SUSPENDED

Research Site, Madrid

SUSPENDED

Research Site, Barcelona

RECRUITING

Research Site, Manchester